02 August 2018
Visiongain has launched a new pharma report Global Healthcare Biometrics Market Forecast 2018-2028: Patient Identification & Tracking, Care Provider Authentication, Medical Record Security & Data Centre Security, Remote Patient Monitoring, Pharmacy Dispensing, Face Recognition, Finger Recognition, Iris Recognition, Vein Recognition, Palm Geometry Recognition, Behavioural Recognition, Hospitals & Clinics, Research & Clinical Laboratory
The biometric technologies including fingerprint recognition, vein recognition, iris recognition, and face recognition are gaining popularity in healthcare sector. The rise in popularity is due to its wide range of applications for health-care provider authentication, patient identification and tracking, medical record security, and data centre security. The growing demand for these biometrics solutions is primarily driven by the need to improve patient confidentiality, and healthcare safety.
In the recent past there has been an increase in the adoption of biometric in the healthcare industry. This integration majorly refers to patient identification and staff authentication. Healthcare industry in the United States is one of the most lucrative industries globally with over 17.9 percent of its Gross Domestic Product being spent on healthcare. According to World Health Organization, U.S. healthcare spending reached USD 2.9 trillion in the year 2013. These facts are indicative of the immense burden healthcare providers’ face on a daily basis to treat patients with a wide range of disorders.
‘’Global healthcare biometrics market is growing rapidly, this is primarily due to increasing awareness about safety and security of patients, increasing application of biometrics devices in healthcare sector application and other data and growing healthcare infrastructure. North America accounts for largest market for healthcare biometrics devices while Asia-Pacific is fastest growing market. Global healthcare biometrics market is expected to grow to $5.02 billion by 2023.’’ – Pharmaceutical Industry Analyst
Leading companies featured in the report include Fujitsi Limited, 3M Congent, Inc.,NEC Corporation, Safran Identity & Security SAS (Morpho), Bio-Key International, Inc., Assa Abloy Group, Imprivata, Inc., Suprema, Inc, Crossmatch Technologies, Inc., Zkteco, Inc.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.
26 November 2020
Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.
26 November 2020
Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.
25 November 2020
Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth